A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches

NCT02160067 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Second generation BTDS patch
DRUG: First generation BuTrans patch

Sponsor

Mundipharma Research Limited